NCT07061067 Affection of Symptoms Duration on Outcomes of Lumbar Spine Surgery
| NCT ID | NCT07061067 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kafrelsheikh University |
| Condition | Symptom Duration |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-07-19 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-07-19 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the affection of symptoms duration on outcomes of lumbar spine surgery.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years old. * Both sexes. * Patients undergoing lumbar spine surgery * Presenting symptoms include lumbar back pain, lumbar radiculopathy, neurogenic claudication, lower-extremity weakness, bowel or bladder symptoms, and duration of symptoms. Exclusion Criteria: * Previous spinal surgery. * Vascular claudication. * Comorbid pathology affecting walking ability. * Severe comorbidities that may impact surgery outcomes (e.g., uncontrolled diabetes, cardiovascular disease). * Bony metastases. * Unfit for general anaesthesia.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07061067 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Symptom Duration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07061067 currently recruiting?
Yes, NCT07061067 is actively recruiting participants. Contact the research team at aymanbasha424@gmail.com for enrollment information.
Where is the NCT07061067 trial being conducted?
This trial is being conducted at Kafr ash Shaykh, Egypt.
Who is sponsoring the NCT07061067 clinical trial?
NCT07061067 is sponsored by Kafrelsheikh University. The trial plans to enroll 60 participants.